Global Allergy Therapeutics Market Insights Forecasts to 2033

• The Global Allergy Therapeutics Market Size was Valued at USD 23.1 Billion in 2023
• The Market Size is Growing at a CAGR of 6.29% from 2023 to 2033
• The Worldwide Allergy Therapeutics Market Size is Expected to Reach USD 42.5 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Allergy Therapeutics Market Size is Anticipated to Exceed USD 42.5 Billion by 2033, Growing at a CAGR of 6.29% from 2023 to 2033.

Market Overview

Allergy therapeutics is the management of various allergic conditions caused by hypersensitivity of the immune system to allergens in the environment. Allergy can be treated by avoiding allergens, medicines, and/or immunotherapy in which allergens are given as a shot or placed under the tongue. Many safe prescription and over-the-counter allergy therapeutics medicines are used to relieve allergy symptoms. The increased trend of personalization and precision therapies increasing the adoption of biological therapies, such as monoclonal antibodies, for the treatment of allergic conditions. An immune protein called IgE, which plays a key role in allergies is the target protein for the new treatment approach. The possible allergy therapeutics that researchers are studying for certain food allergies include oral immunotherapy (OIT), SLIT, and other methods. Technological developments in medicine, such as the creation of novel medication delivery methods like inhalers and nasal sprays, offer prospects to enhance treatment results and patient comfort. These developments may result in more effective and focused allergy treatments. The increasing investment in the development of advanced technologies and rising incidences of asthma are leveraging opportunities for the growth of the allergy therapeutics market.

Report Coverage

This research report categorizes the market for the global allergy therapeutics market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global allergy therapeutics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global allergy therapeutics market.

Driving Factors

The increasing prevalence of allergic conditions like eczema, rhinitis, asthma, and food allergy due to genetic predisposition, and environmental factors, such as exposure to allergens, infections, and air pollution are likely to drive the market demand. The increased awareness about allergies and their impact on health leads to improved diagnosis and therapeutics is propelling the market demand. Further, the rising advancements in biotechnology, genomics, and personalized medicine, allowing tailored treatments are significantly responsible for driving the market growth. The increasing healthcare expenditure and demand for new and improved treatment options for allergy conditions are contributing to bolstering the global allergy therapeutics market.

Restraining Factors

The side effects associated with the drugs for allergy therapeutics are restraining the market. Further, the lack of awareness or limited access to healthcare for the diagnosis and therapeutics of allergies is restraining the global allergy therapeutics market.

Market Segmentation

The global allergy therapeutics market share is classified into treatment type, allergy type, route of administration, and distribution channel.

• The anti-allergy drug segment held the largest share of the global allergy therapeutics market in 2023.   

Based on the treatment type, the global allergy therapeutics market is categorized into anti-allergy drugs and immunotherapy. Among these, the anti-allergy drug segment held the largest share of the global allergy therapeutics market in 2023. Anti-allergy drugs including antihistamines, corticosteroids, and decongestants are used to prevent and treat allergic diseases. The rising development of pediatric-friendly anti-allergy drugs for fulfilling the need for managing allergy conditions in the pediatric population is driving the market

. 

• The rhinitis segment dominated the market with the largest revenue share in 2023.

Based on the allergy type, the global allergy therapeutics market is categorized into eye allergy, asthma, skin allergy, rhinitis, and others. Among these, the rhinitis segment dominated the market with the largest revenue share in 2023. Rhinitis is an allergic reaction triggered by allergens like pollen in the surroundings which triggers the release of histamine in the body causing symptoms of congested or runny nose, frequent sneezing, inflammation, and eye inflammation. It is the most prevalent chronic disease worldwide, including seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis. The increased cases of rhinitis are upsurging the market demand.

• The oral segment is anticipated to hold the largest market share during the forecast period.

Based on the route of administration, the global allergy therapeutics market is categorized into oral, inhalers, intranasal, and others. Among these, the oral segment is anticipated to hold the largest market share during the forecast period. ‘Sudafed’ is an oral allergy therapeutics drug, containing an antihistamine drug, used to relieve symptoms of allergies like rhinitis and insect bites or stings. Oral medication is a convenient and user-friendly option for treatment. Its ease of use and better treatment adherence, especially in pediatric and geriatric are boosting the market.  

• The hospital pharmacies segment is anticipated to grow at the fastest CAGR during the forecast period.

Based on the distribution channel, the global allergy therapeutics market is categorized into hospital pharmacies, retail pharmacies, and others. Among these, the hospital pharmacies segment is anticipated to grow at the fastest CAGR during the forecast period. Medications used by patients receiving care within hospital units, including, intensive care units and surgical units. Allergic reactions need to be treated straight away, thus hospital pharmacies play a crucial role in facilitating quick access to allergy drugs, which helps to manage allergy treatments and improves patients’ general health.

Regional Segment Analysis of the Global Allergy Therapeutics Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global allergy therapeutics market over the predicted timeframe.

North America is projected to hold the largest share of the global allergy therapeutics market over the forecast period. The increasing burden of allergic conditions among the people in the region and increased awareness about the health impact of allergic conditions are driving the market growth. The presence of advanced healthcare systems along with well-established medical facilities, hospitals, clinics, and specialty practices are significantly responsible for driving the market in the region. Further, developments in biotechnology and immunology for the development of advanced allergy therapeutics are propelling the market in the region.

Asia-Pacific is expected to grow at the fastest CAGR growth of the global allergy therapeutics market during the forecast period. The developments in the food allergy treatment options in the region are propelling the market. The increasing prevalence of allergies raising the demand for individualized medication is significantly driving the market. The growing cases of non-communicable diseases with the increasing government programs for their treatment are responsible for escalating the market. The increasing urbanization and continuous healthcare developments in developing countries such as India and China are propelling the market growth in the region. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global allergy therapeutics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GlaxoSmithKline plc.
• F. Hoffmann-La Roche Ltd.
• Allergopharma
• Danahar
• AbbVie, Inc.
• Allergy Therapeutics plc.
• Sanofi SA
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• Merck & Co.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In March 2024, UK-based Allergy Therapeutics commenced dosing of the second part of a Phase I/IIa trial of its subcutaneous virus-like particle (VLP)-based peanut allergy vaccine VLP Peanut.

• In June 2021, the FDA approved Bayer’s Astepro allergy nasal spray as an over-the-counter use for the temporary relief of nasal congestion, runny nose, sneezing, and itchy nose due to hay fever or other upper respiratory allergies.

• In May 2021, Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris -AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India.

• In August 2020, Nestlé and Aimmune Therapeutics, Inc., a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies (Aimmune), entered into a definitive agreement pursuant to which Nestlé Health Science (NHSc) would acquire Aimmune.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global allergy therapeutics market based on the below-mentioned segments: 

Global Allergy Therapeutics Market, By Treatment Type

• Anti-Allergy Drugs
• Immunotherapy

Global Allergy Therapeutics Market, By Allergy Type

• Eye Allergy
• Asthma
• Skin Allergy
• Rhinitis
• Others

Global Allergy Therapeutics Market, By Route Of Administration

• Oral
• Inhalers
• Intranasal
• Others

Global Allergy Therapeutics Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Allergy Therapeutics Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa